Literature DB >> 24621837

Evaluative framework for phase II studies in patients with heart failure and preserved ejection fraction.

Mihai Gheorghiade1, Muthiah Vaduganathan2, Sanjiv J Shah3.   

Abstract

Entities:  

Keywords:  diastolic dysfunction; heart failure with preserved ejection fraction; late sodium current inhibition

Mesh：

Substances：

Year:  2013        PMID： 24621837     DOI： 10.1016/j.jchf.2013.01.001

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  3 in total

1.  Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations.

Authors:  Javed Butler; Carine E Hamo; James E Udelson; Christopher O'Connor; Hani N Sabbah; Marco Metra; Sanjiv J Shah; Dalane W Kitzman; John R Teerlink; Harold S Bernstein; Gabriel Brooks; Christophe Depre; Mary M DeSouza; Wilfried Dinh; Mark Donovan; Regina Frische-Danielson; Robert J Frost; Dahlia Garza; Udo-Michael Gohring; Jennifer Hellawell; Judith Hsia; Shiro Ishihara; Patricia Kay-Mugford; Joerg Koglin; Marc Kozinn; Christopher J Larson; Martha Mayo; Li-Ming Gan; Pierrre Mugnier; Sekayi Mushonga; Lothar Roessig; Cesare Russo; Afshin Salsali; Carol Satler; Victor Shi; Barry Ticho; Michael van der Laan; Clyde Yancy; Norman Stockbridge; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2017-04       Impact factor: 8.790

2.  Matchmaking for the optimization of clinical trials of heart failure with preserved ejection fraction: no laughing matter.

Authors:  Sanjiv J Shah
Journal:  J Am Coll Cardiol       Date:  2013-07-31       Impact factor: 24.094

Review 3.  Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Authors:  Pupalan Iyngkaran; Danny Liew; Peter McDonald; Merlin C Thomas; Christopher Reid; Derek Chew; David L Hare
Journal:  Curr Cardiol Rev       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.